DelveInsight’s “Cancer Cachexia Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Cancer Cachexia, historical and forecasted epidemiology as well as the Cancer Cachexia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

 

Discover Key Insights into the Cancer Cachexia Market with DelveInsight’s In-Depth Report @ Cancer Cachexia Market Size

 

Key Takeaways from the Cancer Cachexia Market Report

• According to the Cancer Cachexia Hub, approximately half of all patients with cancer experience cachexia. This rate of occurrence rises to as high as 86% in the last 1–2 weeks of life, with 45% of patients losing more than 10% of their original body weight over disease progression.
• Several secondary studies suggest that the overall incidence of cachexia is high and in industrialized countries, such as North America, Europe, and Japan it is growing. It is currently estimated that cachexia affects approximately 9 million patients, which is about 1% of all patients with any disease.
• As per a Japanese study conducted by Aoyagi et al. “Cancer cachexia, mechanism and treatment”, cachexia occurs in the majority of terminal cancer patients and is responsible for the death of 22% of cancer patients.
• According to Worp et al. (2020), approximately 70% of gastric cancer patients, 80% of lung cancer patients, and 90% of liver and pancreatic cancer patients are at risk of developing cachexia.
• It is estimated that more than 30% of cancer patients die due to cachexia, and more than 50% of patients die with cachexia being present.
• Among late-stage patients, cachexia affects 50–80% of cancer patients.
• The leading Cancer Cachexia Companies such as AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, and others.
• Promising Cancer Cachexia Therapies such as SAT-003, ponsegromab, Pancrelipase, Anamorelin Hydrochloride, and others.

 

Stay ahead in the Cancer Cachexia Therapeutics Market with DelveInsight’s Strategic Report @ Cancer Cachexia Market Outlook

 

Cancer Cachexia Epidemiology Segmented in the 7MM

• Total Incident cases of Selected Cancer indications for Cancer Cachexia
• Prevalent Cases of Cancer Cachexia
• Treatable cases of Cancer Cachexia

 

Download the report to understand which factors are driving Cancer Cachexia epidemiology trends @ Cancer Cachexia Prevalence

 

Cancer Cachexia Drugs Market

As per DelveInsight, the dynamics of the cancer cachexia market are anticipated to change in the coming years owing to the positive outcomes of some of the rare candidates during the developmental stage by key players, such as Actimed Therapeutics (ACM-001), Aveo Oncology (AV-380), Pfizer (PF 06946860), Extend Biosciences (EXT418) and others that are under early phase of clinical development.

 

Cancer Cachexia Companies

AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, are among others major key players in the Cancer Cachexia therapeutics market. The launch of emerging therapies is expected to create a significant positive shift in the cancer cachexia market size and treatment outlook.

 

Get In-Depth Knowledge on Cancer Cachexia Market Trends and Forecasts with DelveInsight @ Cancer Cachexia Treatment Market

 

Scope of the Cancer Cachexia Market Report

• Coverage- 7MM
• Cancer Cachexia Companies- AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, and others.
• Cancer Cachexia Therapies- SAT-003, ponsegromab, Pancrelipase, Anamorelin Hydrochloride, and others.
• Cancer Cachexia Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
• Cancer Cachexia Unmet Needs, KOL’s views, Analyst’s views, Cancer Cachexia Market Access and Reimbursement

 

Unlock Strategic Insights with DelveInsight’s Comprehensive Cancer Cachexia Market Report @ Cancer Cachexia Market Drivers and Barriers

 

Table of Content

1. Key Insights

2. Executive Summary of Cancer Cachexia (CC)

3. Competitive Intelligence Analysis for Cancer Cachexia (CC)

4. Cancer Cachexia (CC): Market Overview at a Glance

5. Cancer Cachexia (CC): Disease Background and Overview

6. Cancer Cachexia Patient Journey

7. Cancer Cachexia (CC) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Cancer Cachexia Unmet Needs

10. Key Endpoints of Cancer Cachexia Treatment

11. Cancer Cachexia Marketed Products

12. Cancer Cachexia Emerging Therapies

13. Cancer Cachexia (CC): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Cancer Cachexia (CC)

17. KOL Views

18. Cancer Cachexia Market Drivers

19. Cancer Cachexia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/in-licensing-opportunity